NeuroMetrix Board Appointment and Equity Program Termination
Company Announcements

NeuroMetrix Board Appointment and Equity Program Termination

Neurometrix (NURO) has shared an update.

NeuroMetrix, Inc. has announced the appointment of Joshua Horowitz to its Board of Directors, where he’ll serve until the 2025 annual meeting. Horowitz’s new role does not entail any related party transactions that would require reporting. He’ll be compensated with $60,000 in restricted stock units, vesting quarterly, and an $80,000 annual cash payment, alongside indemnification as per the company’s amended agreement. Additionally, NeuroMetrix terminated its existing equity offering program with Ladenburg Thalmann & Co. Inc., with the termination set to be effective within 10 days. These strategic moves, including Horowitz’s appointment, reflect the company’s evolving governance structure and financial strategy.

Learn more about NURO stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskNeuroMetrix Q3 2024: Mixed Results Amid Strategic Review
TheFlyNeuroMetrix reports Q3 revenue $587,314 vs $1.2M last year
TheFlyNeuroMetrix says opportunities reviewed not in best interest at this time
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App